CNL Healthcare Properties, Inc. (CHTH)
USD 2.9
(0.0%)
USD 2.9
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 67.56 Million USD | 10.73% |
| 2022 | 56.83 Million USD | 0.44% |
| 2021 | 60.5 Million USD | -22.68% |
| 2020 | 73.52 Million USD | -11.47% |
| 2019 | 91.02 Million USD | 4.23% |
| 2018 | 75.33 Million USD | -38.76% |
| 2017 | 140.12 Million USD | 2.53% |
| 2016 | 136.67 Million USD | 25.88% |
| 2015 | 81.91 Million USD | 74.29% |
| 2014 | 41.79 Million USD | 182.14% |
| 2013 | 9.55 Million USD | 483.2% |
| 2012 | -9.79 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 18.85 Million USD | 32.59% |
| 2024 Q2 | 22.68 Million USD | 20.3% |
| 2023 Q2 | 17.9 Million USD | 3.37% |
| 2023 Q3 | 17.95 Million USD | 0.26% |
| 2023 Q4 | 14.22 Million USD | -20.78% |
| 2023 Q1 | 17.32 Million USD | 16.47% |
| 2023 FY | - USD | 10.73% |
| 2022 Q3 | 14.35 Million USD | -23.29% |
| 2022 FY | - USD | 0.44% |
| 2022 Q4 | 14.87 Million USD | 3.58% |
| 2022 Q1 | 13.54 Million USD | 238.04% |
| 2022 Q2 | 18.71 Million USD | 38.23% |
| 2021 Q2 | 17.13 Million USD | 18.78% |
| 2021 Q1 | 14.42 Million USD | -22.6% |
| 2021 FY | - USD | -22.68% |
| 2021 Q4 | 4 Million USD | -74.77% |
| 2021 Q3 | 15.87 Million USD | -7.33% |
| 2020 Q3 | 17.67 Million USD | -8.91% |
| 2020 FY | - USD | -11.47% |
| 2020 Q1 | 23.22 Million USD | 2.04% |
| 2020 Q2 | 19.4 Million USD | -16.46% |
| 2020 Q4 | 18.63 Million USD | 5.43% |
| 2019 Q3 | 23.8 Million USD | 24.19% |
| 2019 Q4 | 22.76 Million USD | -4.39% |
| 2019 Q1 | 23.71 Million USD | 69.94% |
| 2019 Q2 | 19.16 Million USD | -19.16% |
| 2019 FY | - USD | 4.23% |
| 2018 Q4 | 13.95 Million USD | -40.2% |
| 2018 FY | - USD | -38.76% |
| 2018 Q3 | 23.33 Million USD | -34.57% |
| 2018 Q2 | 35.66 Million USD | -2.42% |
| 2018 Q1 | 36.54 Million USD | 1.73% |
| 2017 Q1 | 35.18 Million USD | 0.23% |
| 2017 Q4 | 35.92 Million USD | 8.41% |
| 2017 Q3 | 33.13 Million USD | -6.29% |
| 2017 Q2 | 35.36 Million USD | 0.49% |
| 2017 FY | - USD | 2.53% |
| 2016 Q1 | 32.37 Million USD | 2.31% |
| 2016 Q2 | 33.63 Million USD | 3.9% |
| 2016 Q4 | 35.11 Million USD | 0.87% |
| 2016 Q3 | 34.8 Million USD | 3.48% |
| 2016 FY | - USD | 25.88% |
| 2015 FY | - USD | 74.29% |
| 2015 Q3 | 28.61 Million USD | 17.57% |
| 2015 Q2 | 24.33 Million USD | 5.47% |
| 2015 Q1 | 23.07 Million USD | 16.52% |
| 2015 Q4 | 31.64 Million USD | 10.59% |
| 2014 Q1 | 4.89 Million USD | -47.65% |
| 2014 FY | - USD | 182.14% |
| 2014 Q4 | 19.8 Million USD | 18.83% |
| 2014 Q3 | 16.66 Million USD | 23.99% |
| 2014 Q2 | 13.43 Million USD | 174.83% |
| 2013 Q3 | 6.43 Million USD | 346.74% |
| 2013 FY | - USD | 483.2% |
| 2013 Q1 | 1.73 Million USD | -59.9% |
| 2013 Q4 | 9.34 Million USD | 45.2% |
| 2013 Q2 | 1.44 Million USD | -16.81% |
| 2012 Q4 | 4.31 Million USD | 480.86% |
| 2012 Q3 | 743.16 Thousand USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|